Loading

Recall Therapeutics

March 02, 2026
Ballroom II C
Type: Company Presentation
Focus Area: CNS/Neurological
Recall Therapeutics is pioneering a breakthrough platform for memory restoration in Alzheimer’s disease, oncology-related cachexia, and aging-associated sarcopenia.
Recall Therapeutics
Year Founded: 2024
Lead Product in Development: RTX-100 focused on Alzheimer's memory restoration
Speakers
Dan Salain
President & CEO
Recall Therapeutics